TD Cowen lowered the firm’s price target on Establishment Labs (ESTA) to $60 from $75 and keeps a Buy rating on the shares. The firm said Establishment Labs is its EU Best Idea for 2025 driven by their confidence in the US rollout of the Motiva implant.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ESTA:
- Establishment Labs Holdings: Promising Growth Potential and Undervaluation Justify Buy Rating
- Establishment Labs’ Earnings Call: US Success Amid Global Challenges
- Promising Growth and Market Expansion Propel Establishment Labs Holdings’ Positive Outlook
- Establishment Labs Reports Strong Growth and U.S. Expansion
- Establishment Labs Holdings: Strong Growth Prospects Driven by Successful Motiva Launch and Strategic US Expansion